Mandate

Vinge has advised Promimic AB (publ) in connection with its listing on Nasdaq First North Growth Market

Vinge has advised Promimic AB (publ) in connection with its listing on Nasdaq First North Growth Market. The first day of trading is 29 April 2022. In connection with the listing, a shares subscription offer was performed at a subscription price of SEK 16.

Promimic AB is a biomaterials company which produces and markets HAnano Surface, a unique coating for medical implants which strengthens their anchoring in bone tissue. Promimic focuses on the dental and orthopaedic implant market.

Vinge’s team consisted primarily of Anders Strid, Johanna Hamrefält (project manager), Adrian Filipovic, Rebecka Hansson, Anna Högsten and Fredrik Löwenclou.

 

Related

Vinge advises Borgo in connection with its inaugural issuance of primary capital instruments (AT1)

Vinge has advised Borgo AB (publ) in connection with its successful issuance of primary capital instruments (so called “AT1 bonds”) in the amount of SEK 350 million with a floating rate coupon of 3-month STIBOR + 390 basis points.
January 29, 2026

Vinge advises J Bil in conjunction with the acquisition of Appelskog Bil AB

Vinge has advised the buyer J Bil AB in conjunction with the acquisition of all shares in Appelskog Bil AB.
January 29, 2026

Vinge has advised United Lithium Corp. in connection with the acquisition of Swedish Minerals AB

United Lithium is an exploration & development company focused on the global demand for lithium, uranium and rare earth elements.
January 29, 2026